Current Practice and Barriers to an Early Antimicrobial Conversion from Intravenous to Oral among Hospitalized Patients at Jimma University Specialized Hospital: Prospective Observational Study
Table 3
Intravenous to oral antimicrobial therapy conversion outcomes at Jimma University Specialized Hospital, South West Ethiopia, February–September, 2014.
Variable
Implementation
Duration of IV therapy
all patients
mean± SD
7.66 ± 3.25 (n=142)
median; range
7; 0 – 15
converted patients
mean± SD
3.30 ± 2.26 (n=20)
non-converted patients
mean± SD
8.64 ± 2.70 (n=44)
Time to clinical stability (days )
all patients
mean± SD
6.04± 3.25 (n=136)
median; range
5;0 – 16
converted patients
mean± SD
3.40± 2.37 (n=20)
non-converted patients
mean± SD
8.69± 3.73(n=44)
Observation period after conversion (days )
mean± SD
5.18± 4.60 (n=28)
median; range
4.5;0 – 15
Duration of IV therapy after clinical stability for non-converted patients (days)
mean ±SD
3.23± 2.09 (n=44)
median; range
3; 0 – 8
Number of IV antimicrobial prescriptions for which duration was specified (n=total number of prescriptions)